Department of Neurological Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Departments of Psychiatry and Radiology, Columbia University Irving Medical Center, New York, NY, USA.
J Cereb Blood Flow Metab. 2024 Feb;44(2):192-208. doi: 10.1177/0271678X231216766. Epub 2023 Nov 28.
This systematic review, meta-analysis, and novel time course analysis examines microvascular failure in the treatment of acute ischemic stroke (AIS) patients undergoing endovascular therapy (EVT) and/or thrombolytic administration for stroke management. A systematic review and meta-analysis following PRIMSA-2020 guidelines was conducted along with a novel curve-of-best fit analysis to elucidate the time-course of microvascular failure. Scopus and PubMed were searched using relevant keywords to identify studies that examine recanalization and reperfusion assessment of AIS patients following large vessel occlusion. Meta-analysis was conducted using a random-effects model. Curve-of-best-fit analysis of microvascular failure rate was performed with a negative exponential model. Twenty-seven studies with 1151 patients were included. Fourteen studies evaluated patients within a standard stroke onset-to-treatment time window (≤6 hours after last known normal) and thirteen studies had an extended time window (>6 hours). Our analysis yields a 22% event rate of microvascular failure following successful recanalization (95% CI: 16-30%). A negative exponential curve modeled a microvascular failure rate asymptote of 28.5% for standard time window studies, with no convergence of the model for extended time window studies. Progressive microvascular failure is a phenomenon that is increasingly identified in clinical studies of AIS patients undergoing revascularization treatment.
本系统评价、荟萃分析和新的时间进程分析检查了接受血管内治疗 (EVT) 和/或溶栓治疗的急性缺血性卒中 (AIS) 患者的微血管衰竭。按照 PRIMSA-2020 指南进行了系统评价和荟萃分析,并进行了新的最佳拟合曲线分析,以阐明微血管衰竭的时间进程。使用相关关键字在 Scopus 和 PubMed 上搜索了研究,以确定检查大血管闭塞后 AIS 患者再通和再灌注评估的研究。使用随机效应模型进行荟萃分析。使用负指数模型对微血管衰竭率进行最佳拟合曲线分析。纳入了 27 项研究,共 1151 例患者。14 项研究评估了在标准卒中发病至治疗时间窗(最后一次正常后≤6 小时)内的患者,13 项研究的时间窗延长(>6 小时)。我们的分析显示,成功再通后微血管衰竭的发生率为 22%(95%CI:16-30%)。标准时间窗研究中,负指数曲线模拟微血管衰竭率的渐近值为 28.5%,而延长时间窗研究中,该模型没有收敛。渐进性微血管衰竭是在接受血管再通治疗的 AIS 患者的临床研究中越来越多地发现的一种现象。